BrightHeart Unveils Breakthrough AI Results at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting, Revolutionizing Prenatal Care

PARIS--(BUSINESS WIRE)--BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, presented two groundbreaking studies during the oral plenary and concurrent sessions on January 30th at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting, held in Aurora, Colorado. As the first major unveiling of the BrightHeart technology and presentation of key clinical results, these sessions drove significant enthusiasm for BrightHeart’s potential to transform prenatal care.

Previous
Previous

BrightHeart’s AI for Prenatal Heart Defect Detection Receives FDA Clearance

Next
Next

How AI is revolutionizing prenatal detection of congenital heart defects